T HE TGF-␤ SUPERFAMILY of growth and differentiation
factors has been shown to play important roles in regulating mammalian ovarian functions such as follicular development and maturation, production of steroids, and regulation of gonadotropin receptors (1) (2) (3) (4) (5) (6) . Less is known about the role of TGF-␤ superfamily in the ovary of lower vertebrates such as fish. Activin and inhibin have been reported to stimulate oocyte maturation in zebrafish (7) (8) (9) , whereas TGF-␤ has an inhibitory effect on oocyte maturation in zebrafish (10) and steroid production in goldfish (11) . Bone morphogenetic protein-15 (BMP-15) mRNA is highly expressed in the zebrafish ovary, testis, and brain. Neutralization of endogenous BMP-15 enhances basal and human chorionic gonadotropin (hCG)-induced zebrafish oocyte maturation, whereas addition of recombinant human BMP-15 (rhBMP-15) has the opposite effect (12) . Anti-Mü llerian hormone (13) and growth and differentiation factor-9 (GDF-9) (14) are also expressed in zebrafish ovary and may modulate ovarian function.
The discovery of GDF-9 and BMP-15 (also known as GDF-9B) has significantly advanced our understanding of early follicular development, particularly in mammalian systems. GDF-9 is the product of a somatic gene and is expressed in a variety of tissues including ovary, testis, brain, bone, etc. (15, 16) . BMP-15 is the product of an X-linked gene in mammals (17, 18) and was previously reported on chromosome 6 in zebrafish, based on comparison of the cDNA sequence with the zebrafish genomic sequence (12) . However, in the latest version of the zebrafish genome ensemble (http:// www.ensembl.org/Danio_rerio/blastview/), the gene is now assigned to chromosome 7. In mammals, BMP-15 is highly expressed in oocytes (17) (18) (19) and pituitary (20) and to a lesser extent in other tissues (21) . It is widely expressed in zebrafish with the highest expression in gonads (12) .
GDF-9 and BMP-15 are intraovarian regulatory factors. In early, pituitary hormone-independent follicles, they act as mitogens to stimulate the growth and differentiation of granulosa and theca cells and regulate follicular response to FSH (22) , exerting control over the expression of other regulatory factors such as kit ligand (23, 24) and gremlin (25) . Knockout of GDF-9 arrests follicular development at the primary stage in the mouse (26) , whereas naturally occurring mutations in sheep BMP-15 genes such as FecX G,B,I,H,L (27) (28) (29) or the GDF-9 gene FecG H (27) cause primary follicle arrest in homozygous ewes, although interestingly, heterozygous ewes are hyperfertile (30) . Mutations in BMP-15 and GDF-9 genes have also been implicated in human premature ovarian failure (31) (32) (33) (34) . GDF-9 may also play a role in differentiation of primordial follicles because it was recently reported that knockdown of GDF-9 using small interfering RNA blocked the FSH-induced differentiation of somatic cells to primordial follicles in hamsters (35) . In antral follicles, GDF-9 con-trols antrum expansion and steroid synthesis by regulating the expression of cyclooxygenase 2 (Cox2), hyaluronan synthase 2 (Has2), steroidogenic acute regulator protein (StAR), LH receptor, and urokinase plasminogen activator (uPA) (36) . Recent studies suggest BMP-15 acts synergistically with GDF-9 to regulate these factors (37, 38) . They also work cooperatively to stimulate inhibin production and downregulate FSH-induced progesterone secretion (39, 40) and to prevent premature follicular atresia (41) .
Although the important role of BMP-15 in mammalian oocytes has become increasingly clear, there remains scarce information regarding its role in fish ovaries. To better understand the role of BMP-15 in the zebrafish ovary, a series of experiments was conducted. Here we describe the effect of immunoneutralizing endogenous BMP-15 on oocyte maturation in vitro and on follicle numbers in vivo. The effects of BMP-15 knockdown (by N-morpholino oligonucleotide microinjection) or overexpression of BMP-15 [via microinjection of zebrafish BMP-15 (zfBMP-15) expression construct] on oocyte maturation in vitro are also described. Our observations are discussed with regard to the functional role of BMP-15 in zebrafish ovary particularly as pertains to follicular development and oocyte maturation.
Materials and Methods Animals
Zebrafish were obtained from a local supplier (Fish and Bird Emporium, Churchill, Ontario, Canada). Fish were maintained under a 14-h light, 10-h dark cycle at 28 C in 10-liter tanks in a circulating freshwater AHAB system (Aquatics Habitats, Apopka, FL). Fish were fed twice daily, ad libitum, with Basic Food Flakes (Tropic Aquaria, Brampton, Ontario, Canada) supplemented daily with newly hatched brine shrimp (San Francisco Bay Brand, Newark, CA). Fish were killed in accordance with the regulations of the Canada Council for Animal Care. They were anesthetized in tricaine (3-aminobenzoic acid ethyl ester; Sigma-Aldrich Canada, Oakville, Ontario, Canada) and decapitated.
Antiserum
A peptide (MQTFISELGVADIPL) epitope located at the C terminus of zfBMP-15 was selected as the antigen for production of polyclonal antiserum as previously described (12) . Sodium azide (0.02%) was added to the serum as preservative upon receipt from the supplier (Sigma Genosys, Oakville, Ontario, Canada). To remove the sodium azide before in vitro or in vivo application, antiserum or preimmune serum was centrifuged at 4 C for 5 min at 13,000 ϫ g through 10-kDa cutoff Microcon columns (Millipore Corp., Bedford, MA) as per the manufacturer's instructions. The sera were stored at Ϫ20 C until use.
Oocyte maturation assays
Fish were killed as described above. Ovaries from eight to 10 females were excised, rinsed, and placed into sterile Cortland's medium at room temperature (8) . The ovaries were teased into separate follicles using transfer pipettes (Samco Scientific Corp., San Fernando, CA) without trypsinization. Fish follicular development has been classified into five stages (42) : stages I and II, previtellogenic follicles with sizes smaller than 0.34 mm; stage III (0.35-0.69 mm), the growth phase when vitellogenesis takes place; stage IV (greater than 0.69 mm), follicles undergoing maturation; and stage V, mature eggs (Fig. 1) . Previous studies have shown that small stage III follicles (stage III-1, 0.35-0.51 mm) are incompetent to undergo maturation in response to hormones, whereas larger follicles (stage III-2, 0.52-0.69 mm) are sensitive to maturationinducing hormones (MIH) (8, 42, 43) . Therefore, follicles were staged according to their size and oocyte maturation assays conducted as previously described (12) . Briefly, follicles were incubated in 1 ml medium (ϳ20 per well) at 28 C in 24-well culture plates. Cortland's medium (control) was supplemented with BMP-15 antiserum or preimmune serum (1:100 dilution), recombinant hCG (kindly provided by Dr. A. F. Parlow, National Hormone and Peptide Program, Torrance, CA; 100 ng/ml), or the MIH 17␣,20␤-dihydroxyprogesterone (Sigma-Aldrich; 10 ng/ml), as indicated. In some experiments, antiserum was neutralized using 10 g/ml of the synthetic target epitope before incubation. Preincubation experiments were conducted using MIH-insensitive stage III-1 follicles. These follicles were incubated for 18 h with antiserum, preimmune serum, or control media, rinsed, and incubated for either an additional 6 h with control or MIH or for an additional 24 h with control or hCG.
Intraperitoneal injection of gravid zebrafish
Female zebrafish were briefly anesthetized, blotted dry, and weighed. Fish were injected ip (1 l/100 mg body weight) with antiserum, preimmune serum, or saline (Cortland's medium without added BSA), allowed to recover for about 5 min in still water, and then transferred to 3-liter tanks in the AHAB system. A maximum of five similarly injected fish were placed in each tank. Fish were fed normally and killed 72 h after injection. The ovaries from each fish were removed and rinsed in saline. One ovary was placed in a 5-cm culture dish containing clean saline and teased into separate follicles. The follicles were collected and stored in 4% paraformaldehyde in saline at 4 C until counted. The contralateral ovary was rinsed in saline, blotted dry, and flash frozen in liquid nitrogen for future analyses. Fixed follicles were later rinsed in saline to remove the formaldehyde, staged, and counted. The proportion of follicles at various developmental stages was determined for each individual fish.
Expression construct of zfBMP-15
The open reading frame of zfBMP-15 cDNA (GenBank accession number AY954923) (12) was inserted into the pCMV-4B expression vector (Stratagene, La Jolla, CA) upstream of a flag tag and transformed into DH5␣ Escherichia coli cells. Empty vector and zfBMP-15 plasmid DNA was isolated using a high-speed maxi-prep kit (QIAGEN Canada, Mississauga, Ontario, Canada) and quantified by UV spectrophotometry. Human embryonic kidney 293T cells (American Type Culture Collection, Manassas, VA) were transfected with 15 g plasmid DNA using 25-kDa polyethylenimine for 5 h (Sigma) as previously described (44) . The cells were washed and cultured for 48 h in DMEM (Invitrogen) containing 10% fetal bovine serum.
N-morpholino oligonucleotides
The antisense morpholino oligonucleotide spanning the start codon of zfBMP-15 gene (5Ј-CCGCTGGTAGCCTTCATGTTCAGCC-3Ј) and a missense N-morpholino control oligonucleotide (5Ј-CCcCTcGTAGgCTTCATcTTCAcCC-3Ј) were purchased from GeneTools LLC (Philomath, OR).
Microinjection
Ovarian follicles were microinjected with N-morpholino oligonucleotides or rzfBMP-15 plasmid DNA to assess the effects of BMP-15 knockdown or overexpression on oocyte maturation. Glass micropipettes were pulled from 1-mm glass tubes on a WPI model PUL-1 horizontal pipette puller (World Precision Instruments Inc., Sarasota, FL). Microinjection was completed using a WPI model PV830 Pneumatic Pico Pump supplied by nitrogen gas. The pico pump was adjusted until the volume of the microinjected solution was approximately 1 nl, based on the diameter of the solution droplets measured under the dissecting microscope.
For knockdown studies, the N-morpholinos were diluted to 0.5 mm. Antisense or missense oligonucleotides (approximately 0.5 ng/follicle) or water control was injected into stage III-1 follicles. The follicles were allowed to sit at room temperature for 30 -60 min, and any that showed signs of leakage were discarded. The remaining follicles were incubated for 24 h in Cortland's medium and scored for oocyte maturation, and 80 -100 follicles for each injection group were scored in an experiment. For overexpression studies, mid-growth-phase follicles with diameters ranging from 0.50 -0.60 mm were microinjected with zfBMP-15 plasmid DNA or its control vector (1 ng/follicle). The injected follicles were incubated for 6 h, treated with MIH for 6 h or with hCG for 24 h, and scored for oocyte maturation. Each experiment was repeated three to five times.
Protein extraction and Western blotting
The 293T cells were lysed in RIPA buffer and centrifuged at 13,000 ϫ g at 4 C for 30 min to collect the supernatant. Zebrafish follicle lysates were prepared by homogenizing approximately 80 follicles in lysis buffer, followed by 30 sec of sonication. Protein concentration was determined using a Bradford assay (45), and 10 g total protein from BMP-15 overexpression experiments or 20 g total protein from BMP-15 knockdown experiments were separated by SDS-PAGE and transferred to a polyvinylidene difluoride membrane (Millipore). The membrane was washed in Tris-buffered saline/Tween 20 and blocked with 5% skim-milk plus 2% fetal bovine serum in Tris-buffered saline/Tween 20 and probed with zfBMP-15 antiserum (1:2000), anti-flag (Sigma A2220, 1:1000), and anti-acetylated tubulin (Sigma T6793, 1:1000) antibodies. The primary antibodies were removed, the blot was washed and probed with horseradish peroxidase-conjugated secondary antibody [1:5000, antimouse (NA931V) or antirabbit (NAV934V); Amersham Biosciences Inc., Baie d'Urfe, Quebec, Canada] and signal detected by ECL (ECL Plus; Amersham).
Statistical analyses
Where a single stage of follicle was used in an experiment, differences in oocyte maturation were analyzed by one-way ANOVA and StudentNewman-Keuls testing for normally distributed data or Kruskal-Wallis testing when normality testing failed, using InStat (Graphpad Software, San Diego, CA). Results are expressed as mean Ϯ sem for the number of experiments (n) given in each figure. P Յ 0.05 was considered significant, although the P value presented on each figure is the least significant value obtained for that analysis. For the in vitro experiment testing the effect of antiserum on various growth stage follicles (see Fig.  3 ) and the in vivo injection experiment (see Fig. 4 ), the effect of treatment was determined for each stage independently using ANOVA as above.
Results

Effects of BMP-15 antiserum on oocyte maturation in vitro
We have previously shown that incubation with zfBMP-15 antiserum leads to enhanced maturation of zebrafish oocytes (12) . To confirm the specificity of the BMP-15 antiserum, large growth phase follicles were incubated for 24 h in medium containing Cortland's medium (control), antiserum, or preimmune serum with or without neutralizing target epitope ( Fig. 2A) . Maturation was clearly enhanced by the antiserum (P Յ 0.001) but not significantly affected by the preimmune serum. The effect of antiserum on oocyte maturation was neutralized by the addition of the target epitope. Representative micrographs of stage III-2 follicles incubated for 24 h (Fig. 2B ) are provided to illustrate the maturation assay. These results confirm the specificity of the effect of BMP-15 antiserum on zebrafish oocyte maturation.
To determine whether the effect of BMP-15 on oocyte maturation is dependent on the developmental stage of the oocytes, we tested the effect of BMP-15 antiserum on oocyte maturation using different stages of follicles. When we se- lected stage III and IV follicles and divided them into groups based on their sizes, we found that small follicles at early growth phase (stage III-1, 0.35-0.51 mm in diameter), which do not mature in response to MIH, hCG, or activin (8), showed greatest response to the BMP-15 antiserum when compared with the controls. Although the BMP-15 antiserum led to higher mean percentages of oocytes undergoing maturation, no significant differences between the antiserum treatment and the controls were found in later developmental stages (Fig. 3) .
Effects of BMP-15 antiserum on follicular development in vivo
To determine the function of BMP-15 on follicular development, female zebrafish were injected with saline control or antiserum either undiluted, 1:5 diluted, or 1:50 diluted in saline, and 3 d later, the fish were killed and follicles staged and counted as described (Fig. 4A) . Undiluted antiserum produced the most pronounced changes in follicle number, particularly in stage III-1 and stages IV and V (P Յ 0.05), and this concentration was used in subsequent experiments. Gravid females were injected with saline control, antiserum, or preimmune serum and killed 72 h after injection (Fig. 4B) . The follicles from a single ovary of each fish were staged, quantified, and expressed as the percentage of the total number. Neither antiserum nor preimmune serum injection had a significant effect on the number of primary and cortical alveolar follicles. However, antiserum injection caused a very significant decrease (P Յ 0.001) in the number of early growth phase (stage III-1) follicles, compared with control and preimmune serum-injected fish. A concomitant increase in the number of maturing follicles and mature eggs (stages IV and V) was also observed. The BMP-15 antiserum also had a moderate effect on the number of stage III-2 follicles compared with control but was not significantly different from preimmune serum injection. There was no significant difference in follicle numbers between saline and preimmune serum-injected fish.
Effects of BMP-15 antiserum on sensitivity of oocytes to gonadotropin and MIH
The results from both in vitro and in vivo studies suggest that BMP-15 acts on the small growth phase follicles. Because oocytes in this stage are incompetent to undergo maturation in response to LH analog or MIH, we examined whether BMP-15 may play a role in regulating the sensitivity of oocytes to hCG and MIH. Stage III-1 follicles were pretreated with antiserum, preimmune serum, or Cortland's medium (control) for 18 h, followed by incubation with MIH for 6 h (Fig. 5A ) or hCG for 24 h (Fig. 5B ) because MIH and hCG usually induce oocyte maturation after 2-6 and 18 -24 h of incubation, respectively (10) . Similar to previous reports (8, 43) , neither MIH nor hCG induced oocyte maturation in these small early stage follicles. However, in follicles pretreated with BMP-15 antiserum, MIH increased oocyte maturation by 4-fold when compared with the control (Fig. 5A) . Antiserum pretreatment induced 2-to 3-fold higher oocyte maturation rate compared with those preincubated in pre- immune serum or Cortland's medium (Fig. 5A) . However, this increase is statistically significant only in follicles that were further incubated for 24 h (Fig. 5B) . Interestingly, hCG did not enhance oocyte maturation in any of the pretreatment groups (Fig. 5B) .
Effects of zfBMP-15 overexpression and knockdown on oocyte maturation
To further confirm the physiological role of BMP-15 in oocyte maturation, we used microinjection to overexpress BMP-15 or to silence expression of BMP-15 in the zebrafish oocytes. First, an expression plasmid carrying the coding cDNA sequence of zfBMP-15 was made, and the expression of recombinant zfBMP-15 was confirmed in 293 cells. The 293 cells were transfected with the zfBMP-15 cDNA or the empty vector (as negative control); cell lysates were collected at 48 h after transfection and probed with both anti-flag and anti-BMP-15 antisera. As shown in Fig. 6A , both antibodies detected three bands with approximate molecular mass of 45, 28, and 14 kDa in zfBMP-15 cDNA-transfected cells. Similarly, three protein bands were detected in zebrafish oocytes microinjected with zfBMP-15 cDNA but not in its negative control. In mid-growth-phase follicles, microinjection with zfBMP-15 cDNA significantly inhibited (P Յ 0.001) both MIH-induced (Fig. 6B ) and hCG-induced oocyte maturation (Fig. 6C) relative to empty vector injections. On the other hand, microinjection of an antisense N-morpholino oligonucleotide to knock down endogenous BMP-15 produced a significant increase (P Յ 0.001) in oocyte maturation of small growth phase follicles, compared with missense morpholino injection or water control (Fig. 7A) . The efficiency of the antisense oligonucleotide knockdown was confirmed by Western blots (Fig. 7B) .
Discussion
In the present study, we have continued our investigation into the role of BMP-15 in zebrafish ovaries. We confirmed were microinjected with plasmid DNA carrying the coding sequence of zfBMP-15 or its control vector. A, Western blot analysis of BMP-15 in oocyte lysates or 293T cell lysates using anti-flag and anti-BMP-15 antibodies. Equal loading was confirmed by Western blot probed with antitubulin antibody. BMP15, pCMV4B-zfBMP-15; EV, empty vector (pCMV4B). B, Oocytes were injected with zfBMP-15 plasmid DNA and at 6 h after injection incubated with or without MIH (10 ng/ml) for 6 h. C, Oocytes were injected with zfBMP-15 plasmid DNA and at 6 h after injection incubated with or without hCG (100 ng/ml) for 24 h. Bars represent mean Ϯ SEM of four (B) or three (C) experiments. Different letters denote statistical significance (P Յ 0.001).
our previous findings that neutralization of BMP-15 using its antiserum enhances oocyte maturation. We provided novel in vivo data that suggest that BMP-15 mainly acts on early growth phase follicles to inhibit their growth and maturation. Finally, using overexpression and gene-silencing approaches, we showed that knockdown of BMP-15 induced precocious oocyte maturation in early growth phase follicles, whereas overexpression of BMP-15 reduced gonadotropinand MIH-induced oocyte maturation in hormone-sensitive growth phase follicles. Taken together, our findings demonstrate that BMP-15 plays a physiological role in the zebrafish ovary to prevent precocious oocyte maturation.
In the present study, anti-zfBMP-15 antiserum was used in both in vivo and in vitro experiments to determine the role of BMP-15 in the zebrafish ovary. Several lines of evidence suggest that the effect of the antiserum is specific. First, the peptide we used to produce the antiserum was carefully selected to reduce the possibility of cross-reactivity with other related proteins. For example, only four of 15 amino acids are identical to its closest homolog, zebrafish GDF9. Second, the effect of antiserum on oocyte maturation could be reversed by preincubation with the antigen that was used to develop the antiserum. Third, Western blot analyses showed that in zfBMP-15 cDNA-transfected 293 cells or injected zebrafish oocytes, the antiserum detected three protein species with the molecular sizes predicted to be the BMP-15 monomer, dimer, and precursor. These bands were also detected by an anti-flag antibody that reacts to the C-terminal flag tag of the zfBMP-15 expression construct. Finally, knockdown of BMP-15 using an antisense oligonucleotide produced similar effects as BMP-15 antiserum on oocyte maturation. Thus, the effects of BMP-15 antiserum on follicle growth in vivo and oocyte maturation in vitro are most likely due to its ability to neutralize endogenous BMP-15.
One of the most interesting findings of this study is that ip injection of BMP-15 antiserum affects follicular development in vivo. Because it takes about 10 d for follicles to progress through development from stage I to stage V (9, 46), we reasoned that 3 d would be sufficient to determine whether inhibition of endogenous BMP-15 by antiserum injection would have an effect on follicular development. When fish were examined 72 h after injection, BMP-15 antiserum injection caused a significant reduction in the number of stage III-1 follicles and a concomitant rise in the number of maturing and mature (stage IV and V) follicles. The results suggest inhibition of BMP-15 is insufficient to promote precocious development in previtellogenic follicles but can accelerate development in vitellogenic follicles. Immunoneutralization of BMP-15 and GDF-9 has been performed in vivo in sheep, where long-term inoculation leads to sterility in normal ewes (47, 48) , whereas short-term inoculation before the breeding leads to increased fecundity (49) , the effects of antiserum injection mimicking the effects of naturally occurring BMP-15 or GDF-9 gene mutations. Antisera has also been used to neutralize the effect of BMP-15 and GDF-9 in vitro, nullifying the effects of GDF-9 in mouse mural granulosa cells (50) and both GDF-9 and BMP-15 in ovine granulosa cells (40) .
Fish ovarian follicular development is divided into the growth phase and maturation phase. In general, during the growth phase, oocytes accumulate vitellogenin and increase in size under the stimulation of FSH and estrogen (51) . During oocyte maturation, LH induces MIH production (52) and enhances the expression of membrane progestin receptors (mPRs) (53) . MIH binds to the mPRs, leading to activation of maturation-promoting factor and, subsequently, oocyte maturation (54) . It has been reported that stage III-1 follicles do not respond to hCG or MIH (8, 43) . Although the cause of such hormone insensitivity is not clear, several factors, such as activin, have been shown to increase the sensitivity of these follicles to MIH (43, 55, 56) . Interestingly, in the present study, we found that suppression of endogenous BMP-15 expression using a morpholino antisense oligonucleotide or immunoneutralization of BMP-15 using its antiserum induced the precocious maturation of these small follicles. When we tested the effect of BMP-15 antiserum on oocyte maturation using follicles at different stages of development, we found that the BMP-15 antiserum has the most potent effect on oocyte maturation in stage III-1 follicles. Preincubation of stage III-1 follicles with BMP-15 antiserum rendered these follicles sensitive to MIH. However, BMP-15 antiserum did not significantly affect the sensitivity of follicles to hCG. Previously, we have shown that incubation of stage III-2 follicles with human recombinant BMP-15 reduced hCG-induced oocyte maturation to control levels (12). Here we report that microinjection of a zfBMP-15 expression construct into mid-growth-phase follicles also inhibits hCGand MIH-induced oocyte maturation. These findings are consistent with data from the in vivo experiments that suggest that BMP-15 acts on small growth phase follicles to suppress the sensitivity of follicles to hormones and prevent them from undergoing maturation. Although we found that BMP-15 can inhibit premature development and maturation of oocytes, the mechanisms underlying its action are not clear. Suppression of gonadotropin receptors may be a probable mechanism because BMP-15 has been shown to inhibit FSH receptors in mammals (57) . However, this cannot explain the finding that suppression of endogenous BMP-15 by antisense oligonucleotide or antiserum is sufficient to induce oocyte maturation in vitro in the absence of gonadotropin or why hCG does not augment basal oocyte maturation in smaller follicles pretreated with the BMP-15 antiserum. Thus, the most likely sites of action for BMP-15 are the production of MIH and/or MIH receptors. Previously, we have shown that TGF-␤1 down-regulates expression of 20␤-hydroxysteroid dehydrogenase, a key enzyme involved in MIH production, and one of the isoforms of MIH receptors, mPR␤ (58) . These may also be potential targets of BMP-15 in the zebrafish ovary.
In mammals, BMP-15 and GDF-9 play critical roles in early folliculogenesis, but their relative importance appears to be species specific. BMP-15 is necessary for early folliculogenesis in monoovulatory species, such as human and sheep, but not in polyovulatory mice (22, 59 ). Although we did not observe significant effects of BMP-15 antiserum on stage I and stage II follicles in this study, more experimentation, especially with longer-term treatment of BMP-15 antiserum, is necessary to determine whether BMP-15 exerts an effect on early folliculogenesis. GDF-9 may play a role in this process because it has been shown that GDF-9 mRNA is highly expressed in previtellogenic follicles but falls significantly upon uptake of vitellogenin (14) . Whether BMP-15 and GDF-9 protein levels are regulated throughout follicular development and maturation and whether these two factors cooperate to control folliculogenesis in fish remain to be determined.
In summary, using in vivo and in vitro studies along with gain-of-function and loss-of-function approaches, we have demonstrated that BMP-15 exerts regulatory effects of small early growth phase follicles to prevent precocious development and maturation of oocytes in zebrafish, mostly by suppressing their sensitivity to MIH.
